Digitalis

Digitalis is a venture capital firm established in 2016, headquartered in New York City, with additional offices in Boston, Los Angeles, and San Francisco. The firm focuses on investing in innovative solutions addressing complex challenges in both human and animal health. Digitalis collaborates with entrepreneurs, inventors, and scientists throughout various stages of venture investing, supporting a diverse range of technology companies within the healthcare ecosystem. By targeting advancements in health-related technology, Digitalis aims to foster progress that enhances the well-being of both people and animals.

Stephen R. Allen

Partner

Amit Bansal

Partner

Cindy Cole

Technical Partner

Jonathan Friedlander Ph.D

Principal

Dac Nguyen

Technical Partner

Drew Taylor

Partner

76 past transactions

Cayaba Care

Seed Round in 2021
Cayaba Care is a maternal health company offering community-based clinical services via technology-enabled multidisciplinary care teams.

Onc.AI

Venture Round in 2020
Onc.AI is a software that specializes in clinical oncology, genomics, proteomics, and radiomics. The company develops a comprehensive approach to oncology diagnostics and uses deep learning to derive actionable insights into oncology treatment. It was founded in 2020 by Akshay Nanduri and Salmaan Ahmed and is based in San Carlos, California, United States.

Good Therapeutics

Series A in 2019
Good Therapeutics develops new technology for self-regulating drugs that will provide a therapeutic activity when, where it is needed. It is an early-stage biotechnology company based in Seattle, Washington. They are developing context-dependent protein drugs that sense biomarkers and respond with therapeutic activity. Their goal is to make safer, more effective drugs that act only when and where they are needed, limiting systemic toxicity without reducing therapeutic efficacy. Their core technology is an algorithm for designing allosterically-regulated proteins. These proteins change their conformation (shape) when they bind a biomarker or metabolite, and in doing so activate a therapeutic domain. They are currently focused on immuno-oncology applications of the technology.
Ascend supports manufacturing and process development projects from design through to clinical and commercial scales. They partner with biotechnology teams to embed scalable manufacturing in their operations from the beginning. They respond to customer inquiries by phone and contact form.

Terray Therapeutics

Series A in 2022
Terray Therapeutics, Inc. operates as a biotechnology company. The company develops treatments for intractable cause of human diseases. It engages in development of a screening platform for drug discovery and Platinum Technology, which is working on an electrode-like product for deep brain stimulation. The company was founded in 2018 and is based in Pasadena, California.

Scout Bio

Private Placement in 2019
Scout Bio, Inc. researches and develops one-time therapies for major chronic pet health conditions using veterinary biotechnology and gene therapy. It offers therapies for anemia associated with chronic kidney disease (CKD) in cats. The company offers pet therapeutics, including small molecular drugs, protein therapies, and gene therapies. Scout Bio, Inc. was founded in 2016 and is headquartered in Philadelphia, Pennsylvania.

GRO Biosciences

Seed Round in 2018
GRO Biosciences is leveraging breakthrough technologies from computational protein design and synthetic biology to develop best-in-class protein therapeutics with enhanced properties. The company has established multiple genomically recoded strains of bacteria that can incorporate non-standard amino acids into proteins to confer increased potency, stability, and targeted delivery. GRO Biosciences is applying its technology platform to develop improved protein therapeutics for diabetes, growth disorders and autoimmunity. The company, co-founded by Dr. George Church, is located at the Harvard Life Lab, a shared laboratory space for high-potential life sciences and biotechnology startups founded by Harvard faculty, alumni, students, and postdoctoral scholars.

Base5 Genomics

Venture Round in 2020
Base5 Genomics is a developer of sequencing solutions used for personalized care. Its solution reveals the full genomic diversity in humans and other organisms that enable the medical community to give patients the personalized treatment they need. The company was founded in 2018 and is headquartered in Mountain View, California.

AnimalBiome

Venture Round in 2021
AnimalBiome helps to restore gut health to the millions of dogs and cats in the US living with chronic digestive disorders by offering microbiome-based supplements and non-invasive diagnostics.

Kenzen

Seed Round in 2017
Kenzen creates personal health wearables to support its users in all dimensions of health, including wellness, activities, 3D motion, and performance. The company provides its clients with a variety of personal health monitors that report data in real time to smartphone devices. Through its data, Kenzen aims to enable individuals to make critical decisions in training and competitions. Its primary product, Kenzen ECHO, is a small, flexible patch that helps its users understand their physiology, and get personalized health insights and notifications to help improve performance, recovery, and prevent injury. Kenzen was founded in 2014 by Sonia Sousa and Steve Pecko. It is based in San Francisco, California.

UnifiHealth

Seed Round in 2021
UnifiHealth is reimagining how health benefits are built and delivered to small businesses. The company was founded in 2019 and based in Columbus, Ohio.

Aunt Bertha

Private Placement in 2019
Aunt Bertha picks up where Uncle Sam leaves off by making it easy to find and apply for government and charitable social service programs. By organizing the world's human service program information, people in need, and the people who help them can find programs in seconds on. They are driving down the cost of administering social service programs by providing a simple way for governments and charities to accept applications online. Aunt Bertha was founded in 2010 and headquartered in Austin, Texas.

SeQure DX

Venture Round in 2021
SeQure DX is in the business activities at non-commercial site business. It was founded in 2020 and is based in Waltham, Massachusetts.

Nuperfect

Seed Round in 2020
Nuperfect designs and develops invisible orthosis devices. The company develops custom braces from three-dimensional (3D) digital dental model, artificial intelligence, cloud computing, 3D reconstruction, auxiliary diagnosis, and 3D printing. It also provides offline dental scan and home dental mold tool for teeth data. The company offers products through an online portal. Nuperfect was incorporated in 2019 and is based in Shenzhen, China.

MollyBox

Series B in 2018
MollyBox is a subscription-based e-commerce platform for pet-owners. The company offers a monthly themed box of pet foods and supplies. MollyBox was founded in 2015 by Yifu Sun and Yi Ju and is based in Shanghai, China.

Good Therapeutics

Series A in 2020
Good Therapeutics develops new technology for self-regulating drugs that will provide a therapeutic activity when, where it is needed. It is an early-stage biotechnology company based in Seattle, Washington. They are developing context-dependent protein drugs that sense biomarkers and respond with therapeutic activity. Their goal is to make safer, more effective drugs that act only when and where they are needed, limiting systemic toxicity without reducing therapeutic efficacy. Their core technology is an algorithm for designing allosterically-regulated proteins. These proteins change their conformation (shape) when they bind a biomarker or metabolite, and in doing so activate a therapeutic domain. They are currently focused on immuno-oncology applications of the technology.

Pawp

Seed Round in 2019
Pawp gives you unlimited 24/7 access to licensed vets & a $3,000/year pet emergency fund. It’s like pet insurance, but better. You’re covered in any emergency, big or small. Caring for your pet is expensive — Pawp is committed to making it affordable for everyone.

Elemental Machines

Series A in 2018
Elemental Machines is revolutionizing science-based industries with a smart lab platform that offers powerful, data-driven insights to improve laboratory operations, research, development, and manufacturing outcomes. Continuously monitoring equipment and environmental variables provides new levels of clarity, transparency and consistency, and improved repeatability and gathers new data sets for advanced analytics.

The Mighty

Series B in 2019
The Mighty is a digital health community created to empower and connect people facing health challenges and disabilities.

Terray Therapeutics

Seed Round in 2019
Terray Therapeutics, Inc. operates as a biotechnology company. The company develops treatments for intractable cause of human diseases. It engages in development of a screening platform for drug discovery and Platinum Technology, which is working on an electrode-like product for deep brain stimulation. The company was founded in 2018 and is based in Pasadena, California.

CareDox

Series B in 2016
CareDox delivers free health technology for K-12 public schools to help school nurses deliver care and keep students safe. It is a digital health platform for the largest and most consistent health delivery system in the country. Their mission is to work with partners to provide a unified health record for every family. CareDox leverages pediatric health data and this country’s most successful public health organization, the K-12 school system, to improve outcomes and learn about clinical health data outside of the provider’s office. Traditional care coordination stops short of sending essential care instructions to School Nurses and thus increases the risk of stopped or inconsistent post-discharge care delivery. By closing the link in the pediatric care continuum, children stay healthy and get better faster.

Scratch

Series A in 2018
Scratch Financial is the nation's largest provider of simple, pet-friendly payment plans for veterinary care. Scratch Financial partners with veterinary clinics and provides pet owners with simple, friendly payment plans. Pet owners can apply, review, and accept a scratchpay.com payment plan in 90 seconds.

Bonum Therapeutics

Series A in 2022
Bonum Therapeutics is creating a technology platform that can be used to treat a wide range of diseases, including cancer which is the company’s primary therapeutic area of focus—as well as metabolic diseases, immunology, and pain management.

Elemental Machines

Series B in 2022
Elemental Machines is revolutionizing science-based industries with a smart lab platform that offers powerful, data-driven insights to improve laboratory operations, research, development, and manufacturing outcomes. Continuously monitoring equipment and environmental variables provides new levels of clarity, transparency and consistency, and improved repeatability and gathers new data sets for advanced analytics.

Nuvig Therapeutics

Series A in 2022
Nuvig Therapeutics is advancing innovative and transformational therapies that are designed to induce natural mechanisms to restore immune homeostasis, rebalance immune function following inflammation, and improve the treatment options for patients. Nuvig is building a pipeline of novel immune therapeutics for chronic inflammatory and autoimmune diseases.

Switch Therapeutics

Series A in 2023
Switch Therapeutics is a venture-backed startup company that develops a new generation of RNAi therapies based on technology.

GRO Biosciences

Series B in 2024
GRO Biosciences is leveraging breakthrough technologies from computational protein design and synthetic biology to develop best-in-class protein therapeutics with enhanced properties. The company has established multiple genomically recoded strains of bacteria that can incorporate non-standard amino acids into proteins to confer increased potency, stability, and targeted delivery. GRO Biosciences is applying its technology platform to develop improved protein therapeutics for diabetes, growth disorders and autoimmunity. The company, co-founded by Dr. George Church, is located at the Harvard Life Lab, a shared laboratory space for high-potential life sciences and biotechnology startups founded by Harvard faculty, alumni, students, and postdoctoral scholars.

Cardurion Pharmaceuticals

Series B in 2024
Cardurion Pharmaceuticals, LLC operates as a biotechnology company. The company was incorporated in 2017 and is based in Boston, Massachusetts.

Eden Brew

Seed Round in 2022
Eden Brew is a food and beverage company that provides a range of animal-free and precision-fermented milk and dairy products.

Kenzen

Convertible Note in 2018
Kenzen creates personal health wearables to support its users in all dimensions of health, including wellness, activities, 3D motion, and performance. The company provides its clients with a variety of personal health monitors that report data in real time to smartphone devices. Through its data, Kenzen aims to enable individuals to make critical decisions in training and competitions. Its primary product, Kenzen ECHO, is a small, flexible patch that helps its users understand their physiology, and get personalized health insights and notifications to help improve performance, recovery, and prevent injury. Kenzen was founded in 2014 by Sonia Sousa and Steve Pecko. It is based in San Francisco, California.

Aunt Bertha

Series D in 2021
Aunt Bertha picks up where Uncle Sam leaves off by making it easy to find and apply for government and charitable social service programs. By organizing the world's human service program information, people in need, and the people who help them can find programs in seconds on. They are driving down the cost of administering social service programs by providing a simple way for governments and charities to accept applications online. Aunt Bertha was founded in 2010 and headquartered in Austin, Texas.

Smalls

Series A in 2020
Smalls is a direct-to-consumer pet food company that produces human-grade and fresh food for cats. The company's cat food is prepared with human-grade ingredients and offers customized kits as per the cat's nutrition needs, enabling pet owners to get healthy and fresh food directly at their doorstep. It offers variants such as chicken and beef; freeze-dried chicken, and turkey and duck. In 2017, co-founders and best friends Matt Michaelson and Calvin headquartered the company in New York, New York.

UnifiHealth

Seed Round in 2021
UnifiHealth is reimagining how health benefits are built and delivered to small businesses. The company was founded in 2019 and based in Columbus, Ohio.

Ansel Health

Seed Round in 2020
Brella is modernizing supplemental health benefits to build a world where health hardship doesn’t mean financial hardship. Brella’s simple supplemental plan covers 13,000+ conditions and pays cash on the diagnosis that you can use for anything that is needed on the road to recovery. Brella Insurance was founded in 2019 and is based in Hoboken, New Jersey.

PetMedix

Series B in 2021
PetMedix is a development stage veterinary biopharmaceutical company based in Cambridge, UK. they are using the highest quality science to make the therapies their pets need and deserve, keeping them healthier, happier, and for longer. Building on more than thirty years of world-leading innovation and human drug development, they are applying the cutting edge of science to bring breakthroughs for the animals they love and care for.

Scout Bio

Series B in 2019
Scout Bio, Inc. researches and develops one-time therapies for major chronic pet health conditions using veterinary biotechnology and gene therapy. It offers therapies for anemia associated with chronic kidney disease (CKD) in cats. The company offers pet therapeutics, including small molecular drugs, protein therapies, and gene therapies. Scout Bio, Inc. was founded in 2016 and is headquartered in Philadelphia, Pennsylvania.

Scout Bio

Series B in 2021
Scout Bio, Inc. researches and develops one-time therapies for major chronic pet health conditions using veterinary biotechnology and gene therapy. It offers therapies for anemia associated with chronic kidney disease (CKD) in cats. The company offers pet therapeutics, including small molecular drugs, protein therapies, and gene therapies. Scout Bio, Inc. was founded in 2016 and is headquartered in Philadelphia, Pennsylvania.

Terray Therapeutics

Seed Round in 2021
Terray Therapeutics, Inc. operates as a biotechnology company. The company develops treatments for intractable cause of human diseases. It engages in development of a screening platform for drug discovery and Platinum Technology, which is working on an electrode-like product for deep brain stimulation. The company was founded in 2018 and is based in Pasadena, California.

PetMedix

Private Placement in 2019
PetMedix is a development stage veterinary biopharmaceutical company based in Cambridge, UK. they are using the highest quality science to make the therapies their pets need and deserve, keeping them healthier, happier, and for longer. Building on more than thirty years of world-leading innovation and human drug development, they are applying the cutting edge of science to bring breakthroughs for the animals they love and care for.

Good Therapeutics

Series B in 2021
Good Therapeutics develops new technology for self-regulating drugs that will provide a therapeutic activity when, where it is needed. It is an early-stage biotechnology company based in Seattle, Washington. They are developing context-dependent protein drugs that sense biomarkers and respond with therapeutic activity. Their goal is to make safer, more effective drugs that act only when and where they are needed, limiting systemic toxicity without reducing therapeutic efficacy. Their core technology is an algorithm for designing allosterically-regulated proteins. These proteins change their conformation (shape) when they bind a biomarker or metabolite, and in doing so activate a therapeutic domain. They are currently focused on immuno-oncology applications of the technology.

Aunt Bertha

Series C in 2019
Aunt Bertha picks up where Uncle Sam leaves off by making it easy to find and apply for government and charitable social service programs. By organizing the world's human service program information, people in need, and the people who help them can find programs in seconds on. They are driving down the cost of administering social service programs by providing a simple way for governments and charities to accept applications online. Aunt Bertha was founded in 2010 and headquartered in Austin, Texas.

Kenzen

Seed Round in 2019
Kenzen creates personal health wearables to support its users in all dimensions of health, including wellness, activities, 3D motion, and performance. The company provides its clients with a variety of personal health monitors that report data in real time to smartphone devices. Through its data, Kenzen aims to enable individuals to make critical decisions in training and competitions. Its primary product, Kenzen ECHO, is a small, flexible patch that helps its users understand their physiology, and get personalized health insights and notifications to help improve performance, recovery, and prevent injury. Kenzen was founded in 2014 by Sonia Sousa and Steve Pecko. It is based in San Francisco, California.

CareDox

Private Placement in 2016
CareDox delivers free health technology for K-12 public schools to help school nurses deliver care and keep students safe. It is a digital health platform for the largest and most consistent health delivery system in the country. Their mission is to work with partners to provide a unified health record for every family. CareDox leverages pediatric health data and this country’s most successful public health organization, the K-12 school system, to improve outcomes and learn about clinical health data outside of the provider’s office. Traditional care coordination stops short of sending essential care instructions to School Nurses and thus increases the risk of stopped or inconsistent post-discharge care delivery. By closing the link in the pediatric care continuum, children stay healthy and get better faster.

Brella Insurance, Inc.

Private Placement in 2020
Brella Insurance, Inc. provides health insurance plans for employers and their teams. It provides employer insurance plans that cover accident insurance and hospital indemnity for their employees. The company also develops a mobile application and online platform for providing insurance services. Brella Insurance, Inc. was formerly known as Clara Insurance, Inc. and changed its name to Brella Insurance, Inc. in August 2020. The company was incorporated in 2019 and is based in Hoboken, New Jersey.

Code Ocean

Series A in 2021
Code Ocean is a cloud-based computational reproducibility platform that provides researchers and developers an easy way to share, discover, and run code published in academic journals and conferences. The platform provides open access to the published software code and data to view and download for everyone for free. But the real treat is that users can execute all published code without installing anything on their personal computer. Everything runs in the cloud on CPUs or GPUs according to the user needs.

Code Ocean

Series A in 2019
Code Ocean is a cloud-based computational reproducibility platform that provides researchers and developers an easy way to share, discover, and run code published in academic journals and conferences. The platform provides open access to the published software code and data to view and download for everyone for free. But the real treat is that users can execute all published code without installing anything on their personal computer. Everything runs in the cloud on CPUs or GPUs according to the user needs.

GRO Biosciences

Series A in 2021
GRO Biosciences is leveraging breakthrough technologies from computational protein design and synthetic biology to develop best-in-class protein therapeutics with enhanced properties. The company has established multiple genomically recoded strains of bacteria that can incorporate non-standard amino acids into proteins to confer increased potency, stability, and targeted delivery. GRO Biosciences is applying its technology platform to develop improved protein therapeutics for diabetes, growth disorders and autoimmunity. The company, co-founded by Dr. George Church, is located at the Harvard Life Lab, a shared laboratory space for high-potential life sciences and biotechnology startups founded by Harvard faculty, alumni, students, and postdoctoral scholars.

Girihlet

Seed Round in 2018
Girihlet is a provider of rapid and accurate deep sequencing services with a unique focus on developing novel technologies. Girihlet currently specializes in inexpensively sequencing and analyzing mtDNA and T cell receptors using novel, bias-free methods in order to harness their power as biomarkers for diagnostics in a variety of disorders.

Kingdom Supercultures

Series A in 2021
Kingdom Supercultures develops and produces microbial cultures that help food manufacturers to produce new varieties of food. The company produces and offers Koji, a Japanese food ingredient used to make miso, sake, soy sauce, and more. Its products helps in producing fermented sodas, beers, and plant-based dairy replacements. The company offers a platform that uses software and hardware automation to assemble microbial cultures for natural food production. The company was founded in 2019 and is based in Brooklyn, New York.

Ansel Health

Series A in 2021
Brella is modernizing supplemental health benefits to build a world where health hardship doesn’t mean financial hardship. Brella’s simple supplemental plan covers 13,000+ conditions and pays cash on the diagnosis that you can use for anything that is needed on the road to recovery. Brella Insurance was founded in 2019 and is based in Hoboken, New Jersey.

BIOMILQ

Series A in 2021
We leverage our patent-pending technology to produce nutritionally equivalent breastmilk from cultured human mammary cells. With Biomilq, families can achieve the recommended six months of exclusive breastfeeding while alleviating the climate impacts of bovine-based infant formula.

Onc.AI

Private Placement in 2020
Onc.AI is a software that specializes in clinical oncology, genomics, proteomics, and radiomics. The company develops a comprehensive approach to oncology diagnostics and uses deep learning to derive actionable insights into oncology treatment. It was founded in 2020 by Akshay Nanduri and Salmaan Ahmed and is based in San Carlos, California, United States.

PetMedix

Series A in 2019
PetMedix is a development stage veterinary biopharmaceutical company based in Cambridge, UK. they are using the highest quality science to make the therapies their pets need and deserve, keeping them healthier, happier, and for longer. Building on more than thirty years of world-leading innovation and human drug development, they are applying the cutting edge of science to bring breakthroughs for the animals they love and care for.

CareDox

Series C in 2019
CareDox delivers free health technology for K-12 public schools to help school nurses deliver care and keep students safe. It is a digital health platform for the largest and most consistent health delivery system in the country. Their mission is to work with partners to provide a unified health record for every family. CareDox leverages pediatric health data and this country’s most successful public health organization, the K-12 school system, to improve outcomes and learn about clinical health data outside of the provider’s office. Traditional care coordination stops short of sending essential care instructions to School Nurses and thus increases the risk of stopped or inconsistent post-discharge care delivery. By closing the link in the pediatric care continuum, children stay healthy and get better faster.

Second Genome

Series B in 2016
Second Genome’s mission is to transform lives with medicines developed through innovative microbiome science. Second Genome has built a novel platform for microbiome drug discovery. Second Genome has completed more than 400 microbiome studies, analyzing more than 75,000 samples, for internal R&D, as well as for external partners across government, academia, pharmaceutical, nutrition and industrial companies. The team leverages its microbiome analysis platform with its partners’ specific expertise to generate insightful findings that can accelerate research programs by elucidating the role of the microbiome in human health conditions, agriculture, animal health and other industries. The company has established a pipeline of therapeutic products for the treatment of inflammation and metabolic diseases.

Elemental Machines

Private Placement in 2018
Elemental Machines is revolutionizing science-based industries with a smart lab platform that offers powerful, data-driven insights to improve laboratory operations, research, development, and manufacturing outcomes. Continuously monitoring equipment and environmental variables provides new levels of clarity, transparency and consistency, and improved repeatability and gathers new data sets for advanced analytics.

Rejuvenate Bio

Seed Round in 2018
Rejuvenate Bio Inc develops gene therapy which helps to increase the health and life spans of dogs and other domesticated animals. The company offers anti-aging therapies by adding new deoxyribo nucleic acid (DNA) instructions to their bodies. It also offers gene therapies directed at curing specific disease for pets. The company was founded in 2017 and is based in Brookline, Massachusetts.

GRO Biosciences

Seed Round in 2019
GRO Biosciences is leveraging breakthrough technologies from computational protein design and synthetic biology to develop best-in-class protein therapeutics with enhanced properties. The company has established multiple genomically recoded strains of bacteria that can incorporate non-standard amino acids into proteins to confer increased potency, stability, and targeted delivery. GRO Biosciences is applying its technology platform to develop improved protein therapeutics for diabetes, growth disorders and autoimmunity. The company, co-founded by Dr. George Church, is located at the Harvard Life Lab, a shared laboratory space for high-potential life sciences and biotechnology startups founded by Harvard faculty, alumni, students, and postdoctoral scholars.

Somatix

Series A in 2017
Somatix, Inc. develops and provides real-time, wearable remote patient monitoring (RPM) solutions. The company’s solution analyzes massive volumes of gesture data in real time to remotely and passively detect physical and emotional indicators that can provide clinical insights, such as risk factors for adverse events, poor medical compliance, inactivity, falls, and dehydration. It offers SafeBeing, a remote patient monitoring solution for elderly; and SmokeBeat, a smoking cessation passive monitoring solution. The company was incorporated in 2015 and is based in New York, New York.
Shanghai Suoluo Information Technology Co., Ltd. supplies pet goods in China. It has two lines of products: PuffGogo and Mollybox. MollyBox is a subscription based cat food m-commerce platform which provides monthly pet supplies such as cats staple food, snacks and toys. It also operates a platform PuffGogo, which provides information to Chinese pet owners to enhance the life quality of pets in China. The company was founded in 2015 and is based in Shanghai, China.

Scratch

Series B in 2019
Scratch Financial is the nation's largest provider of simple, pet-friendly payment plans for veterinary care. Scratch Financial partners with veterinary clinics and provides pet owners with simple, friendly payment plans. Pet owners can apply, review, and accept a scratchpay.com payment plan in 90 seconds.

Expressable

Series B in 2024
Expressable is an online speech therapy practice for everyone with a communication disorder. It has pioneered a parent-focused care model that uses technology and education to integrate speech therapy techniques into children's daily lives, improving outcomes and experiences. The company was founded in 2019 and is headquartered in Austin, Texas.

Alterome Therapeutics

Series B in 2024
Alterome Therapeutics is a precision oncology biotech developing alteration-specific therapeutics to address high value and validated oncogenic drivers.

Elegen

Series B in 2024
Elegen is a biotechnology company that develops microfluidic technology. It is driven by a mission to deploy this technology in a new generation of DNA synthesizers aimed at enabling and accelerating biomedical advances. The company was founded in 2017 and led by Dr. Matthew Hill.

Eden Brew

Series A in 2023
Eden Brew is a food and beverage company that provides a range of animal-free and precision-fermented milk and dairy products.

Onc.AI

Series A in 2023
Onc.AI is a software that specializes in clinical oncology, genomics, proteomics, and radiomics. The company develops a comprehensive approach to oncology diagnostics and uses deep learning to derive actionable insights into oncology treatment. It was founded in 2020 by Akshay Nanduri and Salmaan Ahmed and is based in San Carlos, California, United States.

Matchpoint Therapeutics

Series A in 2022
Matchpoint is a biotechnology company harnessing the power of covalency to discover precision covalent medicines to transform the treatment of immune diseases and other serious illnesses. The company's proprietary Advanced Covalent Exploration (ACE) platform integrates advanced chemoproteomics, machine learning, and covalent chemistry library evolution. Matchpoint has an emerging pipeline of novel covalent medicines, initially focused on immunology.

Galatea Bio

Seed Round in 2021
Biotech

Faeth

Series A in 2022
Faeth Therapeutics is a data-driven, evidence-based company that specializes in mechanistic understanding of the way that dietary nutrients influence tumor growth and cancer treatment. It fully focuses on matching specific diets with tumor genotypes and treatment regimens to improve the outcomes of cancer therapy. The company was founded to translate breakthrough discoveries, made by cancer research laboratories, into clinical practice. Its founding team includes some of the industry’s preeminent researchers and clinicians.